Literature DB >> 7448110

Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma.

R A Tarala, B W Madsen, J W Paterson.   

Abstract

1 Cumulative dose-response curves (FEV1) to pressurized aerosol salbutamol were established in 17 patients admitted to hospital with acute severe asthma. After the maximal pressurized aerosol effect had been achieved, a further dose (5 mg) of salbutamol was given by wet nebulizer and any further increment recorded. 2 Baseline FEV1 was 1.16 +/- 0.55 (mean +/- s.d.), an average of 36% of predicted, and the maximal aerosol induced change in FEV1 was 0.435 +/- 0.330 1 (t = 5.72, P < 0.01). There was an additional, small increment in FEV1 after nebulizer of 0.043 +/- 0.085 1 (t = 2.26, P < 0.05). 3 Detailed analysis of the data according to a theoretical dose-response relationship showed that the nebulizer-aerosol increment was unrelated to asthma severity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448110      PMCID: PMC1430094          DOI: 10.1111/j.1365-2125.1980.tb01776.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Comparison of two methods of administering bronchodilator aerosol to asthmatic patients.

Authors:  Y F Choo-Kang; I W Grant
Journal:  Br Med J       Date:  1975-04-19

2.  PREDICTION VALUES FOR SCREENING TESTS OF PULMONARY FUNCTION.

Authors:  B G FERRIS; D O ANDERSON; R ZICKMANTEL
Journal:  Am Rev Respir Dis       Date:  1965-02

3.  COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES.

Authors:  A A COHEN; F C HALE
Journal:  Am J Med Sci       Date:  1965-03       Impact factor: 2.378

4.  Aerosol salbutamol administration by IPPB: lowest effective dose.

Authors:  R E Ruffin; G Obminski; M T Newhouse
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

5.  A comparison of three different techniques for giving nebulized albuterol to asthmatic patients.

Authors:  B A Webber; G M Shenfield; J W Paterson
Journal:  Am Rev Respir Dis       Date:  1974-02

6.  Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols.

Authors:  W H Inman; A M Adelstein
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

7.  Normal standards for ventilatory function using an automated wedge spirometer.

Authors:  R M Cherniack; M B Raber
Journal:  Am Rev Respir Dis       Date:  1972-07

8.  A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma.

Authors:  R M Cayton; B Webber; J W Paterson; T J Clark
Journal:  Br J Dis Chest       Date:  1978-07

9.  Investigation into use of drugs preceding death from asthma.

Authors:  F E Speizer; R Doll; P Heaf; L B Strang
Journal:  Br Med J       Date:  1968-02-10
  9 in total
  6 in total

1.  Nebulised fenoterol compared with metered aerosol.

Authors:  C Melville; P D Phelan; L I Landau
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

2.  Comparison of three techniques of inhalation on the airway response to terbutaline.

Authors:  M J Cushley; R A Lewis; A E Tattersfield
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

3.  Maximum or mean FEV1 for bronchodilator aerosol evaluation in acute asthmatics.

Authors:  B W Madsen; B P Murphy; R A Tarala
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 4.  Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.

Authors:  R C Beveridge; A F Grunfeld; R V Hodder; P R Verbeek
Journal:  CMAJ       Date:  1996-07-01       Impact factor: 8.262

Review 5.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

Review 6.  Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.

Authors:  Christopher J Cates; Emma J Welsh; Brian H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2013-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.